Are you Dr. Nejadnik?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 27 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1295 Ustilago Dr
San Ramon, CA 94582Phone+1 925-234-0313- Is this information wrong?
Summary
- Dr. Bijan Nejadnik, MD is a gastroenterologist in San Ramon, California. He is currently licensed to practice medicine in California and Colorado.
Education & Training
Johns Hopkins UniversityFellowship, Gastroenterology, 2002 - 2005
Oregon Health & Science UniversityResidency, Internal Medicine, 1994 - 1996
Cook County Health and Hospitals SystemInternship, Internal Medicine, 1993 - 1994
University Cath De LouvainClass of 1991
Certifications & Licensure
CA State Medical License 1998 - 2024
CO State Medical License 2008 - 2019
Publications & Presentations
PubMed
- 1 citationsDetermining the Minimally Clinically Important Difference for the Disability Rating Scale in Persons With Chronic Traumatic Brain Injury.Flora M Hammond, Jessica M Ketchum, Vipul Vinod Patni, Bijan Nejadnik, Damien Bates, Alan H Weintraub> ;Neurotrauma Reports. 2023 Jan 1
- 2 citationsCell therapies for acute and chronic traumatic brain injury.Masahito Kawabori, Dai Chida, Bijan Nejadnik, Anthony H Stonehouse, David O Okonkwo> ;Current Medical Research and Opinion. 2022 Dec 1
- 3 citationsDetermining minimally clinically important differences for outcome measures in patients with chronic motor deficits secondary to traumatic brain injury.Michael McCrea, Steven C. Cramer, David O. Okonkwo, Soeren Mattke, Susan Paadre, Damien Bates, Bijan Nejadnik, Joseph T. Giacino> ;Expert Review of Neurotherapeutics. 2021 Aug 26
- Join now to see all
Press Mentions
SanBio Announces Publication Comparing Outcome Measures for Persons with Chronic Traumatic Brain Injury in Expert Review of NeurotherapeuticsNovember 1st, 2021
Bijan Nejadnik, M.D., Appointed as Chief Medical Officer of SanBioMay 15th, 2019
Galena Biopharma Presents Positive Interim Safety Data on the NeuVax™ (Nelipepimut-S) Clinical Trial in Combination with Trastuzumab in High-Risk HER2 3+ Patients at the AACR Annual Meeting 2017April 4th, 2017- Join now to see all
